glp-1 receptor agonist type 1 diabetes randomized trial Management of 2 with the dual GIP/GLP-1 tirzepatide: a systematic review and meta-analysis | Diabetologia GLP-1 receptor agonists and cardiovascular

Three RCTs [3234] involving 204 patients provided moderate certainty evidence (Table 2) that L-carnitine supplementation significantly changes in the HDL cholesterol levels (MD: 1.14, 95%CI: 0.21 to 2.07) and low certainty evidence (Table 2) that L-carnitine supplementation may induce or no difference on changes in the LDL cholesterol levels (MD: 6.80, 95%CI: 23.27 to 9.68)

nudge your body to do what it already knows how to do

Mechanistic and regulatory aspects of intestinal iron absorption

Because it has overlapping physiological roles in the body, a folate deficiency can have a very similar clinical picture to B12 deficiency